A Study of RC48-ADC(Antibody Drug Conjugate) and JS001 to Evaluate the Safety and Pharmacokinetics of Subjects With Locally Advanced or Metastatic Urothelial Cancer
Clinical trial NCT04264936 · UNKNOWN
Trial details
- NCT number
- NCT04264936
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-15
- Primary completion
- 2021-01-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.